Purpose: Radiopharmaceutical extravasation can potentially lead to severe soft tissue damage, but little is known about incidence, medical consequences, possible interventions, and effectiveness of these. The aims of this study are to estimate the incidence of extravasation of diagnostic and therapeutic radiopharmaceuticals, to evaluate medical consequences, and to evaluate medical treatment applied subsequently to those incidents.
Methods: A sensitive and elaborate literature search was performed in Embase and PubMed using the keywords "misadministration", "extravasation", "paravascular infiltration", combined with "tracer", "radionuclide", "radiopharmaceutical", and a list of keywords referring to clinically used tracers (i.e. "Technetium-99m", "Yttrium-90"). Reported data on radiopharmaceutical extravasation and applied interventions was extracted and summarised.
Results: Thirty-seven publications reported 3016 cases of diagnostic radiopharmaceutical extravasation, of which three cases reported symptoms after extravasation. Eight publications reported 10 cases of therapeutic tracer extravasation. The most severe symptom was ulceration. Thirty-four different intervention and prevention strategies were performed or proposed in literature.
Conclusions: Extravasation of diagnostic radiopharmaceuticals is common. Tc, I, F, and Ga labelled tracers do not require specific intervention. Extravasation of therapeutic radiopharmaceuticals can give severe soft tissue lesions. Although not evidence based, surgical intervention should be considered. Furthermore, dispersive intervention, dosimetry and follow up is advised. Pharmaceutical intervention has no place yet in the immediate care of radiopharmaceutical extravasation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434120 | PMC |
| http://dx.doi.org/10.1007/s00259-017-3675-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Can ChatGPT help patients understand radiopharmaceutical extravasations?
Front Nucl Med
November 2024
Independent Researcher, Cary, NC, United States.
A previously published paper in the official journal of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) concluded that the artificial intelligence chatbot ChatGPT may offer an adequate substitute for nuclear medicine staff informational counseling to patients in an investigated setting of F-FDG PET/CT. To ensure consistency with the previous paper, the author and a team of experts followed a similar methodology and evaluated whether ChatGPT could adequately offer a substitute for nuclear medicine staff informational counseling to patients regarding radiopharmaceutical extravasations. We asked ChatGPT fifteen questions regarding radiopharmaceutical extravasations.
View Article and Find Full Text PDFDosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging.
Med Phys
November 2024
Advanced Computing for Health Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Article Synopsis
- The study focuses on understanding radiotracer extravasation in PET imaging, an area that hasn't been thoroughly examined but could improve clinical practices.
- It aims to quantify the absorbed radiation doses from extravasation both at the injection site and its effects on nearby organs, while also exploring the biological effects at the cellular level.
- Utilizing advanced simulations, including GATE and TOPAS-nBio, the researchers modeled a common PET scan scenario to calculate radiation doses and assess potential DNA damage from radiation exposure within affected cells.
Case Report: Radiopharmaceutical extravasation, radiation paranoia, and chilling effect.
Front Nucl Med
February 2024
Department of Molecular Imaging, Carilion Clinic, Roanoke, VA, United States.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has publicly commented that they do not support the reporting of large extravasations to patients or regulatory bodies. The comment cites recently published articles suggesting that extravasations are infrequent and not severe. The comment stresses the importance of ensuring patients are not apprehensive or resistant to nuclear medicine procedures because of "radiation paranoia" and a "chilling effect" that can result from misinformation.
View Article and Find Full Text PDFRadiopharmaceutical administration practices-Are they best practice?
Front Nucl Med
October 2023
Vascular Wellness Management Solutions, Cary, NC, United States.
Article Synopsis
- The study evaluated the practices of nuclear medicine technologists in administering radiopharmaceuticals, examining various sources such as clinical observations, quality improvement projects, a survey of hospitals, and extensive IV access data.
- Findings revealed that technologists often choose veins in flexion areas without thorough assessment and primarily rely on blind punctures, contributing to complications like extravasations.
- The research highlighted a lack of formal protocols and training among nuclear medicine technologists, indicating a gap between their intentions and adherence to best practices in venous access.
Treatment of [99mTc]Tc-hydroxy-diphosphonate ([99mTc]Tc-HDP) extravasation using hyaluronidase.
Pharmacol Res Perspect
August 2024
Department of Radiology and Nuclear Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Extravasation of 99mTc-labeled radiopharmaceuticals is generally considered to require no specific intervention. In the presented case, the use of hyaluronidase could have minimized the adverse effects resulting from such an extravasation. Currently, no guidelines exist regarding the use of hyaluronidase after extravasation of [99mTc]Tc-HDP.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!